News Sentiment

TWST sentiment intelligence

Twist Bioscience Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 90.64 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-8.7% over one week, +19.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Twist Bioscience Is Maintained at Buy by Canaccord Genuity

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -8.7% Price reacting lower
Trend fit Trend active 19.0% over four weeks
Fair value 128.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 32
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
Market source 6
Investing.com 6
simplywall.st 4
TradingView 4
Moomoo 3
Investing.com Nigeria 3
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 35
Analyst action 9
Earnings 7
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
Moomoo Direct company coverage

Twist Bioscience Is Maintained at Buy by Canaccord Genuity

Canaccord Genuity has maintained its "Buy" rating for Twist Bioscience (TWST). The article briefly mentions unrelated fourth-quarter financial results for Unity Software, which exceeded revenue estimates but reported a loss per share.

Tone
Positive 70/100
Event
Earnings
Published
15 Jul 2026 14:46
Source
Moomoo
Market source Direct company coverage

Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

Twist Bioscience Corporation (NASDAQ: TWST) announced it will release its fiscal 2026 third-quarter financial results before market open on August 3, 2026. The company will also host a conference call and live audio webcast for analysts and investors at 8:00 AM ET on the same day

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 11:46
Source
Market source
GuruFocus Direct company coverage

TWST Maintained by Canaccord Genuity -- Price Target Raised to $120

Canaccord Genuity maintained a 'Buy' rating for Twist Bioscience (TWST) and raised its price target to $120, citing a positive outlook on the company's growth potential despite its current overvalued status according to GuruFocus. While analysts are optimistic due to Twist Biosci

Tone
Positive 63/100
Event
Analyst action
Published
14 Jul 2026 13:41
Source
GuruFocus
Stock Titan Direct company coverage

[Form 4] Twist Bioscience Corp Insider Trading Activity

Twist Bioscience Corp's CFO, Adam Laponis, sold 2,399 shares of common stock on July 9, 2026, for $94.334 per share. This "sell to cover" transaction was mandatory to meet tax withholding obligations from vesting Restricted Stock Units, not a discretionary sale. Following the sal

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 20:11
Source
Stock Titan
Investing.com Direct company coverage

Twist Bioscience CFO Adam Laponis sells $226,307 in stock

Twist Bioscience CFO Adam Laponis sold $226,307 worth of company stock to cover tax obligations related to Restricted Stock Units, not as a discretionary trade. This transaction occurred as the stock experienced a 9.3% decline over the past week and is considered overvalued by In

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 20:11
Source
Investing.com
Investing.com Canada Direct company coverage

Form 4 Twist Bioscience Corp For: 13 July By Investing.com

This article reports on a Form 4 filing for Twist Bioscience Corp (TWST) on July 13. Form 4 filings are used to report changes in beneficial ownership of company stock by insiders. The article provides the date of the filing and mentions Twist Bioscience Corp's stock symbol.

Tone
Negative 41/100
Event
Market update
Published
13 Jul 2026 20:11
Source
Investing.com Canada
Stock Traders Daily Direct company coverage

(TWST) as a Liquidity Pulse for Institutional Tactics

This article, published on Stock Traders Daily, analyzes Twist Bioscience Corporation (NASDAQ: TWST) as a liquidity pulse for institutional tactics. It provides key findings including weak near-term sentiment but strong mid and long-term outlook, notes compelling upside potential

Tone
Positive 63/100
Event
Guidance
Published
10 Jul 2026 11:09
Source
Stock Traders Daily
Investing.com Nigeria Direct company coverage

Form 144 Twist Bioscience Corp For: 9 July By Investing.com

The article an official Form 144 filing for Twist Bioscience Corp (TWST) on July 9, 2026. Form 144 is a notice of the intent to sell restricted securities. The brief article, published by Investing.com, serves as a record of this financial market activity.

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 22:40
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Officer reports multiple common stock sales (NASDAQ: TWST)

A Form 144 filing by Twist Bioscience Corp (NASDAQ: TWST) indicates that officer Adam Laponis reported multiple sales of common stock between April and May 2026. The filing details specific share counts and proceeds for each transaction, and also mentions a planned security line

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 18:50
Source
Stock Titan
Insider Monkey Direct company coverage

Evercore ISI Raises its Price Target on Twist Bioscience (TWST)

Evercore ISI recently downgraded Twist Bioscience (TWST) to 'In Line' from 'Outperform' but raised its price target to $102, citing a significant stock rally fueled by optimism around AI-driven order momentum. Other firms like Guggenheim and Barclays also increased their price ta

Tone
Positive 66/100
Event
Analyst action
Published
09 Jul 2026 10:50
Source
Insider Monkey
Moomoo Direct company coverage

Evercore Downgrades Twist Bioscience(TWST.US) to Hold Rating, Raises Target Price to $102

Evercore has downgraded its rating on Twist Bioscience (TWST.US) from Outperform to Hold. Despite the downgrade, the firm increased its price target for TWST.US to $102, up from the previous $90. This adjustment reflects Evercore's updated outlook on the company.

Tone
Negative 30/100
Event
Analyst action
Published
06 Jul 2026 16:10
Source
Moomoo
Bitget Direct company coverage

Investment bank Evercore ISI has adjusted its rating on biotechnology company Twist Bioscience Corp (TWST).

Investment bank Evercore ISI has downgraded Twist Bioscience Corp (TWST) from "outperform" to "neutral" while significantly raising its target price from $66 to $102. This adjustment reflects a rebalancing of the bank's expectations for the company's short-term performance and lo

Tone
Neutral 50/100
Event
Analyst action
Published
06 Jul 2026 11:12
Source
Bitget
Finviz Direct company coverage

TWST - Twist Bioscience Corp Options

The article provides a snapshot of Twist Bioscience Corp (TWST) stock, detailing its latest close, financial performance metrics, and various technical and fundamental indicators. It includes information on market capitalization, income, sales, P/E ratios, employee count, and ins

Tone
Negative 38/100
Event
Market update
Published
04 Jul 2026 20:40
Source
Finviz
TradingView Direct company coverage

Twist Bioscience Corp. Actuals & Estimates (SWB:0ME)

This article provides an overview of Twist Bioscience Corp. (SWB:0ME) stock, including analyst forecasts, historical price data, and financial performance. It highlights key financial figures such as earnings per share and revenue for recent quarters, and notes that the company d

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 01:40
Source
TradingView
Investing.com Nigeria Direct company coverage

Twist Bioscience stock hits 52-week high at 104.31 USD By Investing.com

Twist Bioscience (TWST) stock reached a new 52-week high of $104.31, reflecting a 175.61% increase over the past year. This surge is driven by strong investor confidence and positive analyst ratings, with several firms raising price targets due to the company's Q2 revenue beat an

Tone
Positive 71/100
Event
Earnings
Published
02 Jul 2026 08:09
Source
Investing.com Nigeria
Investing.com Direct company coverage

Twist Bioscience stock hits 52-week high at 104.31 USD

Twist Bioscience (TWST) stock has reached a new 52-week high of $104.31, reflecting a 175.61% increase over the past year. This surge is attributed to positive market sentiment and strong analyst ratings, with several firms raising their price targets on the biotech company. Desp

Tone
Positive 70/100
Event
Analyst action
Published
01 Jul 2026 15:09
Source
Investing.com
Investing.com Direct company coverage

Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock

Cathie Wood's ARK ETFs made significant portfolio adjustments, selling over $11 million worth of Twist Bioscience stock while increasing holdings in Circle Internet Group Inc. and SoFi Technologies Inc. ARK also boosted its position in Recursion Pharmaceuticals Inc. but reduced i

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 23:40
Source
Investing.com
Investing.com Direct company coverage

Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock

Cathie Wood's ARK ETFs made several strategic trades on June 29, 2026, significantly increasing its holdings in Coinbase Global Inc and Circle Internet Group Inc, and CoreWeave Inc, signaling continued confidence in digital assets and cloud computing. Conversely, ARK reduced its

Tone
Negative 34/100
Event
Market update
Published
30 Jun 2026 06:40
Source
Investing.com
Simply Wall Street Direct company coverage

Is Twist Bioscience’s (TWST) New ATM Shelf Reshaping Its Capital Structure Or Just Adding Flexibility?

Twist Bioscience (TWST) recently filed a universal shelf registration and an at-the-market (ATM) equity offering for up to US$200 million. This move provides the company with significant financial flexibility, which is crucial given its continued losses despite revenue growth. Th

Tone
Neutral 50/100
Event
Earnings
Published
30 Jun 2026 03:11
Source
Simply Wall Street
TradingView Direct company coverage

Price to earnings forward of Twist Bioscience Corporation – NASDAQ:TWST

This article provides financial information for Twist Bioscience Corporation (NASDAQ: TWST) on TradingView. It specifically focuses on the company's price to earnings forward metric. The content includes general financial and market data, but not specific numeric values for the f

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 08:40
Source
TradingView
Investing.com Nigeria Direct company coverage

Form 4 Twist Bioscience Corp For: 26 June By Investing.com

This article reports on a Form 4 filing for Twist Bioscience Corp, dated June 26, 2026. Form 4 filings disclose changes in ownership of company stock by insiders. The article includes the stock symbol TWST and its performance, but no further details about the filing itself.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 17:40
Source
Investing.com Nigeria
Moomoo Direct company coverage

Twist Bioscience Stock Rises as Investors Continue to Reward Stronger Growth Outlook and Margin Progress

Twist Bioscience (TWST) stock increased following an analyst's reiterated "buy" rating and price target increase, driven by improved growth and margin outlooks. The company is benefiting from increased demand in its Synthetic Biology segment and its next-generation sequencing pro

Tone
Positive 70/100
Event
Analyst action
Published
27 Jun 2026 06:40
Source
Moomoo
TradingView Direct company coverage

Price to sales forward of Twist Bioscience Corporation – NASDAQ:TWST

This article provides a brief financial overview of Twist Bioscience Corporation (NASDAQ: TWST), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or a section from a larger financial data platform like TradingView, offering a snapshot of a key va

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 05:39
Source
TradingView
Investing.com Direct company coverage

Twist Bioscience CEO Emily Leproust sells $1.79m in stock

Emily M. Leproust, CEO of Twist Bioscience Corp (NASDAQ:TWST), sold $1.79 million worth of common stock on June 25, 2026, through a pre-established trading plan. This sale occurred while the stock was trading near its 52-week high, having surged 205% year-to-date. Despite the str

Tone
Negative 38/100
Event
Market update
Published
27 Jun 2026 05:39
Source
Investing.com